An insight on hyaluronic acid in drug targeting and drug delivery

References

• Abney JR, Braun J, Owicki JC. Lateral interactions among membrane proteins. Implications for the organization of gap junctions. Biophys J 1987; 52: 441–454
   PubMed Web of Science ®Google Scholar
• Akima K, Ito H, Iwata Y, Matsuo K, Watari N, Yanagi M, Hagi H, Oshima K, Yagita A, Atomi Y, Tatekawa I. Evaluation of antitumor activities of hyaluronate binding antitumor drugs: Synthesis, characterization and antitumor activity. J Drug Target 1996; 4: 1–8
   PubMed Web of Science ®Google Scholar
• Arimura H, Ouchi T, Kishida A, Ohya Y. Preparation of hyaluronic acid hydrogel through polyion complex formation using cationic polylactide-based micropheres as a biodegradable cross-linking agent. J Biomater Sci Polym Ed. 2005; 16: 1347–58
   PubMed Web of Science ®Google Scholar
• Aruffo A, Stamenkovic I, Melnick M, Underhill CB. CD44 is the principal cell surface receptor for hyaluronate. Cell 1990; 61: 1303
   PubMed Web of Science ®Google Scholar
• Balazs EA, Denlinger JL. Clinical uses of hyaluronan. Ciba Found Symp 1989; 143: 265–275
   PubMedGoogle Scholar
• Balazs EA. The physical properties of synovial fluid and the special role of hyaluronic acid in disorder of the knee, AJ Helert. Liincott, Philadelphia 1982; 61–75
   Google Scholar
• Barbault-Foucher S, Gref R, Russo P, Guechot J, Bochot A. Design of poly-ε-caprolactone nanospheres coated with bioadhesive hyaluronic acid for ocular delivery. J Control Release 2002; 83: 365–375
   PubMed Web of Science ®Google Scholar
• Benedetti L, Cortivo R, Berti T, Berti A, Pea F, Mazzo M, Moras M, Abatangelo G. Biocompatibility and biodegradation of different hyaluronan derivatives (HYAFF) implanted in rats. Biomaterials 1993; 14: 1154–1160
   PubMed Web of Science ®Google Scholar
• Benedetti LM, Topp EM, Stella VJ. Microspheres of hyaluronic acid esters—fabrications methods and in vitro hydrocortisone release. J Control Release 1990; 13: 33–41
   Web of Science ®Google Scholar
• Bertolami CN, Berg S, Messadi DV. Binding and internalization of hyaluronate by human cutaneous fibroblasts. Matrix 1992; 12: 2397–2404
   Google Scholar
• Bjork E, Edman P. Characterisation of degradable starch microspheres as a nasal delivery system for drugs. Int J Pharm 1990; 62: 187–192
   Web of Science ®Google Scholar
• Bochard G, Luessen HL, deBoer AG, Verhoef JC, Lehr CM, Junginger HE. The potential of mucoadhesive polymers in enhancing intestinal peptide drug absorption. 3: Effects of chitosan-glutamate and carbomer on epithelial tight junctions in vitro. J Control Release 1996; 39: 131–138
   Web of Science ®Google Scholar
• Cera C, Palumbo M, Stefanelli S, Rassu M, Palu G. Water-soluble polysaccharide–anthracycline conjugates: Biological activity. Anticancer Drug Des. 1992; 7: 143
   PubMedGoogle Scholar
• Chien YW, Chang SF. Transnasal systemic medications. Fundamentals, development concepts and biomedical assessment, YW Chien. Elsevier, Amsterdam 1985; 1–99
   Google Scholar
• Cho KY, Chung TW, Kim BC, Kim MK, Lee JH, Wee WR, Cho CS. Release of ciprofloxacin from poloxamer-graft-hyaluronic acid hydrogels in vitro. Int J Pharm 2003; 260: 83–91
   PubMed Web of Science ®Google Scholar
• Collis L, Hall C, Lange L, Ziebell M, Prestwich G, Turley E. Rapid hyaluronan uptake is associated with enhanced motility: Implications for an intracellular mode of action. FEBS Lett 1998; 440: 444–449
   PubMed Web of Science ®Google Scholar
• Culty M, Nguyen HA, Underhill CB. The hyaluronan receptor (CD44) participates in the uptake and degradation of hyaluronan. J Cell Biol 1992; 116: 1055–1062
   PubMed Web of Science ®Google Scholar
• Duchateau GSMJE, Zuidema J, Merkus FWHM. Bile salts and intranasal drug absorption. Int J Pharm 1986; 31: 193–199
   Web of Science ®Google Scholar
• Eliaz RE, Szoka FC, Jr. Liposome-encapsulated doxorubicin targeted to CD44 a strategy to kill CD44-overexpressing tumor cells. Cancer Res 2001; 61: 2592–2601
   PubMed Web of Science ®Google Scholar
• Entwistle J, Hall CL, Turley EA. Hyaluronan-based microspheres as tools for drug delivery: A comparative study. J Cell Biochem 1996; 61: 569–577
   PubMed Web of Science ®Google Scholar
• Esposito E, Menegatti E, Cortesi R. Hyaluronan-based microspheres as tools for drug delivery: A comparative study. Int J Pharm 2005; 288: 35–49
   PubMed Web of Science ®Google Scholar
• Farraj NF, Johansen BR, Davis SS, Illum L. Nasal administration of insulin using bioadhesive microspheres and lysophosphatidylcholine as a delivery system. J Control Release 1990; 13: 253–261
   Web of Science ®Google Scholar
• Fisher AN, Brown K, Davies SS, Parr GD, Smith DA. The effect of molecular size on the absorption of water-soluble compounds in the albino rat. J Pharm Pharmacol 1987; 39: 357–362
   PubMed Web of Science ®Google Scholar
• Fraser JRE, Laurent TC, Laurent UBG. Hyaluronan: Its nature, distribution, functions and turnover. Intern Med 1997; 242: 27–33
   Web of Science ®Google Scholar
• Freed LE, Vunjak-Novakovic G, Biron RJ, Eagles DB, Lesnoy DC, Barlow SK, Langer R. Biodegradable polymer scaffolds for tissue engineering. Biotechnology 1994; 12: 689–693, New York
   PubMed Web of Science ®Google Scholar
• Gerdin B, Hallgren R. Dynamic role of hyaluronan (HYA) in connective tissue activation and inflammation. J Intern Med 1997; 242: 49–55
   PubMed Web of Science ®Google Scholar
• Gianolio DA, Philbrook M, Avila LZ, MacGregor H, Duan SX, Bernasconi R, Slavsky M, Dethlefsen S, Jarrett PK, Miller RJ. Synthesis and evaluation of hydrolyzable hyaluronan-tethered bupivacaine delivery systems. Bioconjug Chem 1994; 16: 1512–1518
   Google Scholar
• Goa KL, Benfield P. Hyaluronic acid: A review of its pharmacology and use as a surgical aid in ophthalmology, and its therapeutic potential in joint disease and wound healing. Drugs 1994; 47: 536–566
   PubMed Web of Science ®Google Scholar
• Gustafson S, Björkman T. Circulating hyaluronan, chondroitin sulphate and dextran. Glycoconj J 1997; 14: 561–568
   PubMed Web of Science ®Google Scholar
• Gustafson S, Björkman T, Westlin JE. Labelling of high molecular weight hyaluronanwith 125I-tyrosine: Studies in vitro and in vivo in the rat. Glycoconj J 1994; 608: 613
   Google Scholar
• Hahn SK, Oh EJ, Miyamoto H, Shimobouji T. Sustained release formulation of erythropoietin using hyaluronic acid hydrogels crosslinked by Michael addition. Int J Pharm 2006; 322: 44–51
   PubMed Web of Science ®Google Scholar
• Hall CL, Yang BH, Yang XW, Zhang SW, Turley M, Samuel S, Lange LA, Wang C, Curpen GD, Savani RC, Greenberg AH, Turley EA. Overexpression of the hyaluronan receptor RHAMM is transforming and is also required for h-ras transformation. Cell 1995; 82: 19–28
   PubMed Web of Science ®Google Scholar
• Hardwick C, Hoare K, Owens R, Hohn HP, Hook M, Moore D, Cripps V, Austen L, Nance DM, Turley EA. Molecular cloning of a novel hyaluronan receptor that mediates tumor cell motility. J Cell Biol 1992; 117: 1343–1350
   PubMed Web of Science ®Google Scholar
• Hirai S, Yashiki T, Mima H. Effects of surfactants on the nasal absorption of insulin in rats. Int J Pharm 1981; 9: 165–172
   Web of Science ®Google Scholar
• Hoare K, Savani RC, Wang C, Yang B, Turley EA. Identification of hyaluronan binding proteins using a biotinylated hyaluronan probe. Connect Tissue Res 1993; 30: 117–126
   PubMed Web of Science ®Google Scholar
• Huang LY, Yang MC. Hemocompatibility of layer-by-layer hyaluronic acid/heparin nanostructure coating on stainless steel for cardiovascular stents and its use for drug delivery. J Nanosci Nanotechnol 2006; 6: 3163–3170
   PubMed Web of Science ®Google Scholar
• HyACTTM Anti-Cancer Technology. 2004. Summary of Pre-Clinical and Clinical Development Meditech Research Ltd Non-Confidential Information Package, p 1–8
   Google Scholar
• Illum L, Farraj NF, Critchley H, Davis SS. Nasal administration of gentamicin using a novel microsphere delivery system. Int J Pharm 1988; 46: 261–265
   Web of Science ®Google Scholar
• Illum L, Farraj NF, Fisher AN, Giu I, Miglietta M, Benedetti LM. Hyaluronic acid ester microspheres as nasal delivery systems for insulin. J Control Release 1994; 29: 133–141
   Web of Science ®Google Scholar
• Illum L. Bioadhesive formulations for nasal peptide delivery. Bioadhesive drug delivery systems, fundamentals, novel approaches and development, E Mathiowitz. Marcel Dekker, New York 1999; Vol. 136: 477–601
   Google Scholar
• Ito T, Fraser IP, Yeo Y, Highley CB, Bellas E, Kohane DS. Antiinflammatory function of an in situ cross-linkable conjugate hydrogel of hyaluronic acid and dexamethasone. Biomaterials 2007; 28: 1778–1786
   PubMed Web of Science ®Google Scholar
• Jaracz S, Chen J, Kuznetsova LV, Ojima I. Recent advances in tumortargeting anticancer drug conjugates. Bioorg Med Chem 2005; 13: 5043–5054
   PubMed Web of Science ®Google Scholar
• Kim A, Checkla DM, Chen W. Characterization of DNA-hyaluronan matrix for sustained gene transfer. J Control Release 2003; 90: 81–95
   PubMed Web of Science ®Google Scholar
• Knudson W. Tumor-associated hyaluronan: Providing an extracellular matrix that facilitates invasion. Am J Pathol 1996; 148: 1721–1726
   PubMed Web of Science ®Google Scholar
• Kurisawa M, Chung JE, Yang YY, Gao SJ, Uyama H. Injectable biodegradable hydrogels composed of hyaluronic acid-tyramine conjugates for drug delivery and tissue engineering. Chem Commun (Camb) 2005; 14: 4312–4314
   Web of Science ®Google Scholar
• Langer R. Biomaterials in drug delivery and tissue engineering: One laboratory's experience. Acc Chem Res 2000; 33: 94–101
   PubMed Web of Science ®Google Scholar
• Laurent TC, Laurent UBG, Fraser JRE. Functions of hyaluronan. Ann Rheum Dis 1995; 54: 429–432
   PubMed Web of Science ®Google Scholar
• Laurent TC. Structure of hyaluronic acid in chemistry and molecular biology of the intercellular matrix. Academic Press, New York 1970; 703
   Google Scholar
• Leach JB, Schmidt CE, Austin TX. Photocrosslinkable hyaluronic acid hydrogels for tissue engineering. Mat Res Soc Symp Proc 2004; EXS-1: F4 7.1–7.4
   Google Scholar
• Lee NA, Narog BA, Patapoff TN, Wang YJ. Intranasal bioavailability of insulin powder formulations: Effect of permeation enhancer to protein ratio. J Pharm Sci 1991; 80: 725–778
   PubMed Web of Science ®Google Scholar
• Lim ST, Forbes B, Berry DJ, Martin GP, Brown MB. In vivo evaluation of novel hyaluronan/chitosan microparticulate delivery systems for the nasal delivery of gentamicin in rabbits. Int J Pharm 2002; 231: 73–82
   PubMed Web of Science ®Google Scholar
• Lim ST, Martin GP, Berry DJ, Brown MB. Preparation and evaluation of the in vitro drug release properties and mucoadhesion of novel microspheres of hyaluronic acid and chitosan. J Control Release 2000; 66: 281–292
   PubMed Web of Science ®Google Scholar
• Lisbeth RL, Hume YK, Benedetti L, Sanzgiri YD, Topp EM, Stella V. Ocular sustained delivery of prednisolone using hyaluronic acid benzyl ester films. Int J Pharm 1994; 111: 295–298
   Google Scholar
• Luká Z, Dvorak K. Adhesion molecules in biology and oncology. Acta Vet Brno 2004; 73: 93–104
   Web of Science ®Google Scholar
• Luo Y, Bernshaw NJ, Lu ZR, Koecek J, Prestwich GD. Targeted delivery of doxorubicin by HPMA copolymer–hyaluronan bioconjugates. Pharm Res 2002; 19: 396–402
   PubMed Web of Science ®Google Scholar
• Luo Y, Prestwich GD. Synthesis and selective cytotoxicity of a hyaluronic acid-antitumor bioconjugate. Bioconjug Chem 1999; 10: 755–763
   PubMed Web of Science ®Google Scholar
• Luo Y, Kirker KR, Prestwich GD. Cross-linked hyaluronic acid hydrogel films: New biomaterials for drug delivery. J Control Release 2000; 69: 169–184
   PubMed Web of Science ®Google Scholar
• Lv FF, Zheng LQ, Tung CH. Phase behavior of the microemulsions and the stability of the chloramphenicol in the microemulsion-based ocular drug delivery system. Int J Pharm 2005; 301: 237–246
   PubMed Web of Science ®Google Scholar
• Maeda H, Seymour L, Miyamoto Y. Conjugates of anticancer agents and polymers: Advantages of macromolecular therapeutics in vivo. Bioconjugate Chem 1992; 3: 351–362
   PubMed Web of Science ®Google Scholar
• Matsuno H, Yudoh K, Hashimoto M, Himeda Y, Miyoshi T, Yoshida K, Kano S. A new antibacterial carrier of hyaluronic acid gel. J Orthop Res 2006; 24: 321–326
   PubMed Web of Science ®Google Scholar
• Mckee CM, Penno MB, Cowman M, Burdict MD, Strieter RM, Bao C, Noble PW. Hyaluronan (HA) fragment induce chemikine gene expression in alveolar macrophares. The role of Ha size and CD44. J Clin Invest 1996; 98: 2403–2413
   PubMed Web of Science ®Google Scholar
• Mensiteri M, Ambrosio L, Nicolas D, O'regan B. Viscoelastic properties modulation of a noval hyaluronic acid polymer. J Mater Sci Mater Med 1996; 7: 695–698
   Web of Science ®Google Scholar
• Meo CD, Panza L, Capitani D, Mannina L, Banzato A, Rondina M, Renier D, Rosato A, Crescenzi V. Hyaluronan as carrier of carboranes for tumor targeting in boron neutron capture therapy. Biomacromolecules 2007; 8: 552–559
   PubMed Web of Science ®Google Scholar
• Meyer K, Palmer JW. The polysaccharide of the vitreous humor. J Biol Chem 1934; 107: 629–634
   Google Scholar
• Mishima M, Nakita Y, Nakano M. Studies on thepromoting effects of medium chain fatty-acid salts on the nasal absorption of insulin in rats. J Pharmacobiodyn 1987; 10: 624–631
   PubMedGoogle Scholar
• Motoawa k, Hahn SK, Nakamura T, Miyamoto H, Shimoboji T. Selectively crosslinked hyaluronic acid hydrogels for sustained release formulation of erythropoietin. J Biomed Mater Res A 2006; 78: 459–65
   PubMedGoogle Scholar
• Morales J, Kelleher PJ, Campbell D, Crosson CE. Effects of daunomycin implant on filtering surgery outcomes in rabbits. Curr Eye Res 1998; 17: 844–850
   PubMed Web of Science ®Google Scholar
• Morimoto K, Morisaka K, Kamada A. Enhancement of nasal absorption of insulin and calcitonin using polyacrylic acid gel. J Pharm Pharmacol 1985; 37: 134–136
   PubMed Web of Science ®Google Scholar
• Nelson RM, Venot A, Bevilacqua MP, Linhardt RJ, Stamenkovic I. Carbohydrate–protein interactions in vascular biology. Annu Rev Cell Dev Biol 1995; 601: 631
   Google Scholar
• Peppas NA, Langer R. New challenges in biomaterials. Science 1994; 263: 1715–1720
   PubMed Web of Science ®Google Scholar
• Pouyani T, Prestwich GD. Biotinylated hyaluronic acid: A new tool for probing hyaluronate–receptor interactions. Bioconj Chem 1994a; 5: 370–372
   PubMed Web of Science ®Google Scholar
• Pouyani T, Prestwich GD. Functionalized derivatives of hyaluronic acid oligosaccharides: Drug carriers and novel biomaterials. Bioconj Chem 1994b; 5: 339–347
   PubMed Web of Science ®Google Scholar
• Prehm P. Hyaluronan. Biopolymers: Biology, chemistry, biotechnology, applications, polysaccharides I. Polysaccharides from prokaryotes, EJ Vandamme, S De Baets, A Steinbüchel. Wiley-VCH, Weinheim 2000; Vol. 5: 379–404
   Google Scholar
• Prestwich GD, Marecak DM, Marecek JF, Vercruysse KP, Ziebell MR. The chemistry, biology, and medical applications of hyaluronan and its derivatives, TC Lauret. Portland Press, Miami, FL 1998; 43–65
   Google Scholar
• Pritchard K, Lansley AB, Martin GP, Helliwell M, Marriott C, Benedetti LM. Evaluation of the bioadhesive properties of hyaluronan derivatives: Detachment weight and mucociliary transport rate studies. Int J Pharm 1996; 129: 137–145
   Web of Science ®Google Scholar
• Rajewski LG, Stinnett AA, Stella VJ, Topp EM. Enzymic and non-enzymic hydrolysis of a polymeric prodrug: Hydrocortisone esters of hyaluronic acid. Int J Pharm 1992; 82: 205–213
   Google Scholar
• Richardson JL, Ramires PA, Miglietta MR, Rochira M, Bacelle L, Callegaro L, Benedetti L. Novel vaginal delivery systems for calciton. Evaluation of HYAFF/calcitonin microspheres in rats. J Int Pharm 1995; 115: 9–15
   Web of Science ®Google Scholar
• Rooney P, Kumar S, Ponting J, Wang M. The role of hyaluronan in tumour neovascularization (review). Int J Cancer 1995; 60: 632–636
   PubMed Web of Science ®Google Scholar
• Rosato A, Banzato A, De Luca G, Renier D, Bettella F, Pagano C, Esposito G, Zanovello P, Bassi P. HYTAD1-p20: A new paclitaxel–hyaluronic acid hydrosoluble bioconjugate for treatment of superficial bladder cancer. Urol Oncol 2006; 24: 207–215
   PubMed Web of Science ®Google Scholar
• Ruhela D, Riviere K, Szoka FC, Jr. Efficient synthesis of an aldehyde functionalized hyaluronic acid and its application in the preparation of hyaluronan–lipid conjugates. Bioconjug Chem 2006; 17: 1360–1363
   PubMed Web of Science ®Google Scholar
• Sakurai K, Andoh M, Yamada M, Kodera Y, Nishimura H, Hiroto M, Matsushima A, Aoyama M, Yamamoto H, Inada Y. Suppression of ischemic edema in mice by manganese–hyaluronate conjugate. Jpn J Pharmacol 1997; 74: 117–120
   PubMedGoogle Scholar
• Sandri G, Bonferoni MC, Chetoni P, Rossi S, Ferrari F, Ronchi C, Caramella C. Ophthalmic delivery systems based on drug–polymer–polymer ionic ternaryinteraction: In vitro and in vivo characterization. Eur J Pharm Biopharm 2006; 62: 59–69
   PubMed Web of Science ®Google Scholar
• Schipper NGM, Varum KM, Ocklind G, Stenberg P, Lennernas H, Artursson P. Chitosan as absorption enhancers of poorly absorbable drugs 3: Influence of mucus. Eur J Pharm Sci 1999; 8: 335–343
   PubMed Web of Science ®Google Scholar
• Surendrakumar K, Martyn GP, Hodgers ECM, Jansen M, Blair JA. Sustained release of insulin from sodium hyaluronate based dry powder formulations after pulmonary delivery to beagle dogs. J Control Release 2003; 91: 385–394
   PubMed Web of Science ®Google Scholar
• Tengamnuay P, Mitra AK. Bile salts fatty acid mixed micelles as nasal absorption promoters of peptides. 2. In vivo nasal absorption of insulin in rats and effects of mixed micelles on the morphological integrity of the nasal mucosa. Pharm Res 1990; 7: 370–375
   PubMed Web of Science ®Google Scholar
• Termeer CC, Hennies J, Voith U, Ahrens T, Weiss JM, Prehm P, Simon JC. Oligosaccharides of hyaluronan are potent activators of dendritic cells. J Immunol 2000; 165: 1863–1870
   PubMed Web of Science ®Google Scholar
• Tombs M, Harding SE. An introduction to polysaccharide biotechnology. Taylor and Francis, London 1998
   Google Scholar
• Toole BP. Hyaluronan and its binding proteins, the hyaladherins. Curr Opin Cell Biol 1990; 2: 839–844
   PubMed Web of Science ®Google Scholar
• Toole BP. Hyaluronan in morphogenesis. J Intern Med 1997; 242: 35–40
   PubMed Web of Science ®Google Scholar
• Turley EA, Belch AJ, Poppema S, Pilarski LM. Expression and function of a receptor for hyaluronan-mediated motility on normal and malignant lymphocytes-B. Blood 1993; 81: 446–453
   PubMed Web of Science ®Google Scholar
• Uchiyama H, Dobashi Y, Ohkouchi K, Nagasawa K. Chemical change involved in the oxidative reductive depolymerization of hyaluronic acid. J Biol Chem 1990; 265: 7753–7759
   PubMed Web of Science ®Google Scholar
• Valenta C. The use of mucoadhesive polymers in vaginal delivery. Adv Drug Deliv Rev 2005; 57: 1692–1712
   PubMed Web of Science ®Google Scholar
• Wang W. A novel hydrogel crosslinked hyaluronan with glycol chitosan. J Mater Sci Mater Med 2006; 17: 1259–1265
   PubMed Web of Science ®Google Scholar
• West DC, Hampson IN, Arnold F, Kumar S. Increased hyaluronan at sites of attachment to mesentery by CD44-positive mouse ovarian and breast tumor cells. Science 1985; 228: 1324–1326
   PubMed Web of Science ®Google Scholar
• Yeo TK, Nagy JA, Yeo KT, Dvorak HF, Toole BP. Increased hyaluronan at sites of attachment to mesentery by CD44-positive mouse ovarian and breast tumor cells. Am J Pathol 1996; 148: 1733–1740
   PubMed Web of Science ®Google Scholar
• Yerushalmi N, Arad A, Margalit R. Molecular and cellular studies of hyaluronic acid-modified liposomes as bioadhesive carriers for topical drug delivery in wound healing. Arch Biochem Biophy 1994; 313: 267–273
   PubMed Web of Science ®Google Scholar
• Yun YH, Goetz DJ, Yellen P, Chen W. Hyaluronan microspheres for sustained gene delivery and site-specific targeting. Biomaterials 2004; 25: 147–157
   PubMed Web of Science ®Google Scholar